Acknowledgements
Digestive, NASH, Nonalcoholic Steatohepatitis, Diabetes, Cancer
CANCER, KIDNEY DISEASES, NONALCOHOLIC STEATOHEPATITIS, DIABETES
We thank the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) investigators and the Ancillary Studies Committee for providing clinical samples and relevant data from the TONIC trial, and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for its support of the NASH CRN and this research. This ancillary study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grants U01DK061713, U01DK061718, U01DK061728, U01DK061732, U01DK061734, U01DK061737, U01DK061738, U01DK061730, U24DK061730). The TONIC trial was conducted by the NASH CRN and supported in part by the Intramural Research Program of the National Cancer Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The vitamin E and matching placebo were provided by Pharmavite through a Clinical Trial Agreement with the NIH. Trial protocol and more details about the trial can be accessed by contacting Laura Wilson (author on this paper).